Clearside Biomedical Inc (CLSD) Stock
CLSD is no longer traded. Clearside Biomedical was delisted from the Nasdaq in November 2025.
Prices on this page are historical; the last trade was November 28, 2025 at $0.41.
Clearside Biomedical stock price history
CLSD final trading statistics
- Final close
- $0.41
- Final trading day
- Nov 28, 2025
- Market cap at delisting
- $2.15M
- Shares outstanding
- 5.23M
- Final 52-week range
- $0.29 – $4.57
- Avg. volume (final 3 mo.)
- 75,751
- All-time high (split-adj.)
- $370.80 · Oct 2016
- All-time low (split-adj.)
- $0.41 · Nov 2025
- Return since IPO
- -99.6%
- Beta
- 1.79
- Book value / share
- -$10.31
- Price / book
- -0.04
Clearside Biomedical annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $1.66M | -$34.4M | -$0.45 |
| FY2023 | $8.23M | -$32.5M | -$0.53 |
| FY2022 | $1.33M | -$32.9M | -$0.55 |
| FY2021 | $29.57M | $376.0K | -$0.01 |
| FY2020 | $7.89M | -$18.0M | -$0.39 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Clearside Biomedical Inc
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. On November 23, 2025, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Clearside Biomedical stock FAQ
What happened to Clearside Biomedical stock?
Clearside Biomedical stock was delisted from the Nasdaq. Its final close was $0.41 on November 28, 2025.
Is CLSD stock still trading?
No. CLSD was delisted from the Nasdaq in November 2025 and no longer trades on a U.S. exchange.
What was the last price of CLSD stock?
CLSD closed at $0.41 on its final trading day, November 28, 2025, for a market value of about $2.15M.
What were Clearside Biomedical's revenue and earnings in its last full fiscal year?
Clearside Biomedical reported revenue of $1.66M and net income of -$34.4M in fiscal 2024, its last full year as a public company.
When did Clearside Biomedical go public?
Clearside Biomedical Inc stock began trading on June 2, 2016.